Articles

Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT

Section of Hematology, Cliniques Universitaires St-Luc, Brussels, Belgium
Acute Leukemia Working Party of the EBMT;Sorbonne Université, Paris, France;INSERM UMR 938, Paris, France;Service d’Hématologie, Hôpital Saint-Antoine, Paris, France
Acute Leukemia Working Party of the EBMT;Sorbonne Université, Paris, France;INSERM UMR 938, Paris, France;Service d’Hématologie, Hôpital Saint-Antoine, Paris, France
CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland
Service d’Hématologie, Centre Hospitalier Lyon Sud, Lyon, France
Institut Paoli Calmette, Programme de Transplantation Thérapie Cellulaire, Marseille, France
CHU de Lille, LIRIC INSERM U995, Université Lille2, Lille, France
University Hospital Gasthuisberg, Leuven, Belgium
Servicio de Hematologica-Hemoterapia, Hospital U. Marquès de Valdecilla, Santander, Spain
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Department of Medicine-Hematology-Oncology, University of Freiburg, Freiburg, Germany
Acute Leukemia Working Party of the EBMT;Sorbonne Université, Paris, France;INSERM UMR 938, Paris, France;Service d’Hématologie, Hôpital Saint-Antoine, Paris, France
Hematology Department, Hospital Clinic, Barcelona, Spain
Acute Leukemia Working Party of the EBMT;Sorbonne Université, Paris, France;Chaim Sheba Medical Center, Tel-Hashomer, Israel
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2019.216168